Breast Cancer

Showing NaN - NaN of 241

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Biomarkers in Subjects With Untreated Solid Tumors

Completed
  • Breast Cancer
  • +12 more
  • Blood Sample Collection
  • Phoenix, Arizona
  • +118 more
Aug 31, 2022

Malignant Tumor of Breast, Breast Cancer Trial in United States (Genomically Directed Monotherapy, Observation/Standard Therapy)

Active, not recruiting
  • Malignant Neoplasm of Breast
  • Breast Cancer
  • Genomically Directed Monotherapy
  • Observation/Standard Therapy
  • Birmingham, Alabama
  • +28 more
Aug 30, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Breast Cancer Trial in Worldwide (LY3484356)

Recruiting
  • Breast Cancer
  • Atlanta, Georgia
  • +19 more
Aug 17, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

Available
  • Non Small Cell Lung Cancer
  • +6 more
  • Goodyear, Arizona
  • +67 more
Aug 17, 2022

Breast Cancer, Cancer Trial in Worldwide (Nivolumab, Anastrozole, Palbociclib)

Completed
  • Breast Cancer
  • Cancer
  • Nivolumab
  • +2 more
  • Whittier, California
  • +35 more
Jul 14, 2022

Breast Cancer Trial in Worldwide (biological, drug, other, procedure)

Active, not recruiting
  • Breast Cancer
  • nivolumab
  • +6 more
  • Mobile, Alabama
  • +255 more
Jul 21, 2022

Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)

Active, not recruiting
  • Breast Cancer
  • Tucson, Arizona
  • +167 more
Jul 19, 2022

Ovarian Cancer, Breast Cancer, Folic Acid Deficiency Trial in Chicago (Folic Acid Tablet)

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Folic Acid Tablet
  • Chicago, Illinois
    Rush University Medical Center
Jul 17, 2022

Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)

Active, not recruiting
  • Breast Cancer
  • Anchorage, Alaska
  • +495 more
Jun 15, 2022

Advanced or Metastatic Solid Tumors, Ovarian Cancer, NSCLC Trial in United States (NC762)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • +3 more
  • New Haven, Connecticut
  • +6 more
Jun 22, 2022

Breast Cancer Trial in United States (therapeutic conventional surgery, whole breast irradiation)

Active, not recruiting
  • Breast Cancer
  • therapeutic conventional surgery
  • whole breast irradiation
  • Hot Springs, Arkansas
  • +349 more
Jun 16, 2022

Quality of Life in Female Breast Cancer Survivors and Their

Completed
  • Breast Cancer
  • +5 more
  • cognitive assessment
  • +2 more
  • Monterey, California
  • +103 more
Jun 8, 2022

Breast Cancer Trial in United States (Lapatinib, Letrozole, Trastuzumab)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +7 more
May 15, 2022

Breast Cancer, Triple Negative Breast Cancer, Residual Cancer Trial in United States (Atezolizumab, Sacituzumab govitecan)

Recruiting
  • Breast Cancer
  • +3 more
  • San Francisco, California
  • +8 more
May 25, 2022

Breast Cancer Trial in Worldwide (Enzalutamide, exemestane, Placebo (for enzalutamide))

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +132 more
Apr 26, 2022

Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Amcenestrant-matching placebo
  • +5 more
  • Daphne, Alabama
  • +299 more
May 5, 2022

Breast Cancer Trial in Ireland, United States (bevacizumab, docetaxel, doxorubicin)

Completed
  • Breast Cancer
  • Bessemer, Alabama
  • +532 more
Apr 13, 2022

Breast Cancer Trial in Chicago, Wauwatosa (Taking Charge during Treatment (TCT) Intervention)

Recruiting
  • Breast Cancer
  • Taking Charge during Treatment (TCT) Intervention
  • Chicago, Illinois
  • +1 more
Apr 11, 2022

Diabetes, Breast Cancer Trial in Chicago, New Hyde Park, New York (Integrated Intervention for Breast Cancer Survivors with

Recruiting
  • Diabetes
  • Breast Cancer
  • Integrated Intervention for Breast Cancer Survivors with Diabetes
  • Attention Control
  • Chicago, Illinois
  • +2 more
Apr 13, 2022

Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)

Active, not recruiting
  • Breast Cancer
  • Mobile, Alabama
  • +437 more
Mar 21, 2022

Breast Cancer, Renal Cell Carcinoma Trial in United States (IPI-549 (eganelisib), Atezolizumab, nab-paclitaxel)

Active, not recruiting
  • Breast Cancer
  • Renal Cell Carcinoma
  • IPI-549 (eganelisib)
  • +3 more
  • Chandler, Arizona
  • +23 more
Apr 1, 2022

Breast Cancer Trial in United States (Tucatinib in Combination with Palbociclib and Letrozole)

Active, not recruiting
  • Breast Cancer
  • Tucatinib in Combination with Palbociclib and Letrozole
  • Tucson, Arizona
  • +5 more
Mar 8, 2022

Breast Cancer Trial in United States (Mifepristone, Placebo, Nab-Paclitaxel)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +4 more
Mar 14, 2022